menu
    • menu

    Company profile for NextPharma Technologies Holding Ltd

    NEW Drugs in Dev: 1
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    NextPharma is a world class outsourcing partner to the pharmaceutical and biotechnology industry. We offer a full range of services from early phase product development through clinical trial packaging (Phases I through III) to commercial manufacturing.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NextPharma Technologies Holding Ltdunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Connaught House, Portsmouth Road
    Telephone
    Telephone
    44 148 347 9120
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://nextpharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BOS Manchester 2024
    BOS Manchester 2024

    27 Sep 2024

    // PRESS RELEASE

    https://nextpharma.com/news-events/article-detail/aaps-pharmsci-2024-salt-lake-city-1

    PRESS RELEASE
    27 Sep 2024
    Share Share
    NextPharma at PBP - World Meeting
    NextPharma at PBP - World Meeting

    31 Jan 2024

    // PRESS RELEASE

    https://nextpharma.com/news-events/article-detail/nextpharma-at-pbp-world-meeting

    PRESS RELEASE
    31 Jan 2024
    Share Share
    NextPharma Acquires Chewable Tablets Manufacturing Site in Norway
    NextPharma Acquires Chewable Tablets Manufacturing Site in Norway

    04 Apr 2023

    // CONTRACT PHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2023-04-04/nextpharma-acquires-chewable-tablets-manufacturing-site-in-norway/?widget=listSection

    CONTRACT PHARMA
    04 Apr 2023
    Share Share
    Acquisition of manufacturing site in Asker, Norway completed
    Acquisition of manufacturing site in Asker, Norway completed

    02 Feb 2023

    // PRESS RELEASE

    https://nextpharma.com/news-events/article-detail/nextpharma-schliesst-uebernahme-der-produktionsstaette-fuer-kautabletten-in-asker-norwegen-ab

    PRESS RELEASE
    02 Feb 2023
    Share Share
    Skye Bioscience Selects NextPharma as Phase 2 Contract Drug Manufacturer
    Skye Bioscience Selects NextPharma as Phase 2 Contract Drug Manufacturer

    21 Jul 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/07/21/2483485/0/en/Skye-Bioscience-Selects-NextPharma-as-Phase-2-Contract-Drug-Manufacturer.html

    GLOBENEWSWIRE
    21 Jul 2022
    Share Share
    Lonza Completes Divestment of Sites to NextPharma
    Lonza Completes Divestment of Sites to NextPharma

    01 Apr 2021

    // CONTRACTPHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2021-04-01/lonza-completes-divestment-of-sites-to-nextpharma/?widget=listSection

    CONTRACTPHARMA
    01 Apr 2021
    Share Share

    Drugs in Development

    read-more
    read-more
    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Bioavailability Study With Oral Single Dose Administration of Ethinylestradiol and Dienogest

    Details:

    Dienogest is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.


    Lead Product(s): Dienogest,Ethinyl Estradiol

    Therapeutic Area: Undisclosed Brand Name: Undisclosed

    Study Phase: UndisclosedProduct Type: Miscellaneous

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable May 17, 2012

    blank

    01

    NextPharma Technologies Holding Ltd

    United Kingdom
    arrow
    PEGS Boston Summit
    Not Confirmed

    NextPharma Technologies Holding Ltd

    United Kingdom
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Dienogest,Ethinyl Estradiol

    Therapeutic Area : Undisclosed

    Highest Development Status : Undisclosed

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Bioavailability Study With Oral Single Dose Administration of Ethinylestradiol and Dienogest

    Details : Dienogest is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    May 17, 2012

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search